How Do You Taper Off Lunesta (Eszopiclone) Safely?

Is Lunesta a benzodiazepine, and why does the answer matter?

Eszopiclone, sold as Lunesta, is a prescription sleep medication. Its prescribing information, approved by the United States Food and Drug Administration (FDA), calls it a nonbenzodiazepine hypnotic, meaning a sleeping pill that is not, chemically, a benzodiazepine. It belongs to the group patients know as the z-drugs, alongside zolpidem, zopiclone and zaleplon.

So, if it is not a benzodiazepine, why does a benzodiazepine tapering practice write about it? Because the brain does not sort drugs by their chemistry. The Lunesta label calls the mechanism unclear but says the effect could come from an interaction with the gamma-aminobutyric acid (GABA) receptor complex, at binding sites close to or coupled with the benzodiazepine receptors.

The Ashton Manual puts it more bluntly. In Chapter I, Professor C. Heather Ashton lists eszopiclone in Table 1 under “non-benzodiazepines with similar effects,” with a footnote that these drugs are chemically different from benzodiazepines but have the same effects on the body and act by the same mechanisms. A drug that acts at the same site produces the same dependence, and that is why a Lunesta taper looks like a benzodiazepine taper.

Nightly use for months produces physical dependence, and that is not addiction.

The Lunesta label defines physical dependence as a state of adaptation that shows itself as a withdrawal syndrome when the drug is stopped abruptly or reduced too quickly. It also warns of withdrawal signs after rapid dose decreases or abrupt discontinuation. The Ashton Manual adds that every drug in Table 1 is meant for short-term use only, two to four weeks.

Many of the people who arrive at Dr. Leeds’ practice on Lunesta have taken it every night for years, exactly as prescribed, and never once took more than the bottle said. Their nervous system has adapted to the drug and now needs it to function normally. That is a medical condition caused by a prescription, and dependence is not addiction.

The distinction decides the treatment. Adaptation needs a slow, medically supervised way down, not a program built for a different condition.

What is the difference between rebound insomnia and withdrawal?

Rebound insomnia is the first thing most people notice: after a missed dose, sleep is worse than it ever was before the drug was started. That feels like proof the medication is needed, and it is nothing of the kind. It is an adapted nervous system being asked to run a night without the drug.

Withdrawal is the wider syndrome. The Lunesta label lists anxiety, abnormal dreams, nausea and stomach upset within two days of the drug being replaced by placebo in clinical trials, and those trials were short. After years of nightly use, patients commonly describe what patients coming off benzodiazepines describe: daytime anxiety, irritability, restlessness, and sleep that comes and goes for weeks rather than nights.

The Manual warns in Chapter II that abrupt or over-rapid withdrawal from benzodiazepines, especially from high doses, can cause severe symptoms, convulsions among them. The Lunesta label says withdrawal after a rapid dose decrease looks like withdrawal from other central nervous system depressants, and a drug that acts at the same site earns the same caution. The Manual adds that rushing also raises the risk of symptoms that drag on long after the last dose, which is the second reason the pace stays slow.

A seizure is a medical emergency, and anyone who has one should call 911 or be taken to the nearest emergency room. Fortunately, seizures are a complication of stopping fast, and stopping fast is the one thing a supervised taper never does.

Why is the Ashton Manual the framework for a Lunesta taper?

The Ashton Manual, published free at benzo.org.uk, is the standard reference for coming off benzodiazepines slowly. Its withdrawal schedules in Chapter II are built around diazepam, and the only z-drug among them is Schedule 12, for zopiclone, the parent compound of eszopiclone. There is no Lunesta schedule anywhere in it.

Schedule 12 is instructive all the same. Professor Ashton notes there that zopiclone can be withdrawn directly using its smallest tablet, but that the steps are then rather abrupt, which is her case for diazepam substitution in a single sentence.

What the Manual does supply is a place for eszopiclone in its equivalence table and principles that apply to it fully. Table 1 puts Lunesta 3 mg at roughly the strength of diazepam 10 mg, with Professor Ashton’s own caution that equivalents vary between individuals. The principles apply in full: reduce slowly, let the patient control the rate, and never let an outsider talk the patient into a rapid withdrawal.

The Maudsley Deprescribing Guidelines supply the rest. They cover the z-drugs, eszopiclone included, and describe hyperbolic reductions, where each cut is a proportion of the current dose rather than a fixed amount, so the steps shrink as the dose falls. Dr. Leeds’ Ashton Manual page explains how he applies both.

There are two supervised routes off Lunesta, and neither adds a benzodiazepine on top.

The first route is a direct taper of eszopiclone itself. Lunesta comes as 1 mg, 2 mg and 3 mg tablets, which serve the early steps but not the late ones, where fractions of a milligram are needed. A liquid or compounded preparation of eszopiclone solves that, and the taper follows the hyperbolic shape: small proportional cuts, a hold after each one until sleep and daytime symptoms settle, then the next cut. A compounded taper is the drug itself in a smaller or liquid form, with nothing mixed in, no herb and no supplement.

The second route, for some patients, is a crossover taper to diazepam. Chapter II explains why diazepam is the substitute: its half-life runs up to 200 hours, so the blood level falls smoothly, and it comes in 2 mg tablets that halve cleanly into 1 mg. Eszopiclone, with a half-life of about six hours, is a bucket with a hole in it, and diazepam is a reservoir that drains slowly. So the crossover is made one dose at a time, the night dose first, and only when the switch is complete does the diazepam taper begin.

A benzodiazepine is never prescribed alongside Lunesta to take the edge off withdrawal, and no second sleeping pill is added either. The Manual tells patients withdrawing from benzodiazepines not to reach for zolpidem, zopiclone or zaleplon because they have the same actions, and the logic runs both ways: two drugs at the same receptor are one larger dependence.

How long does a Lunesta taper take?

Months. The Manual’s answer about benzodiazepines applies here: whether withdrawal takes 6 months, 12 months or 18 months is of little significance to someone who has taken the drug for years.

People searching for Lunesta detox usually have a facility stay of a week or two in mind. That is the one thing z-drug dependence does not need. What it needs is a gradual, medically supervised taper over months, at home, with the patient’s own sleep and symptoms setting the pace.

If a cut lands hard, Dr. Leeds slows the taper or holds the dose until things settle. If the cuts are landing easily, patient and doctor may agree to go a little faster, as tolerated. A hold is not a failure, and a slower taper is not a weaker one.

What about sleep while the dose comes down?

Sleep will be uneven for a while, and it is better to say so than to promise otherwise. The brain’s own sleep regulation has been suppressed by the drug and takes time to reassert itself, so sleep tends to return in pieces, with the good weeks slowly winning.

Sleep habits are support, not treatment. A fixed wake time, a dark and cool room and screens off in the last hour give a healing brain fewer obstacles, but they do not replace the drug, and no supplement does either.

What does informed consent look like before a Lunesta taper?

Risks first. Before anything is reduced, the patient hears what a taper involves, what withdrawal can feel like, and what the alternatives are, including staying on the current dose for now. The exit plan is on the table from the first conversation, and the patient may pause, slow down or stop the taper at any point without losing the doctor.

Many patients were never given a real consent conversation when the drug was started. They are owed one when it is stopped.

Questions patients ask about tapering off Lunesta.

Is Lunesta a benzodiazepine?

No. Its FDA label calls it a nonbenzodiazepine hypnotic of the cyclopyrrolone class whose effect is thought to come from the same GABA receptor complex, near the benzodiazepine binding site. That is why it produces the same kind of physical dependence and is tapered by the same principles.

Can Lunesta be stopped cold turkey after years of nightly use?

It should not be. Rebound insomnia is nearly certain, a wider withdrawal syndrome is likely, and the Ashton Manual warns that abrupt withdrawal from high doses of benzodiazepines can end in convulsions, while the Lunesta label says its withdrawal resembles that of other central nervous system depressants. A slow, supervised taper over months avoids that, and a seizure is always a reason to call 911.

Does the Ashton Manual cover Lunesta?

Partly. Table 1 lists eszopiclone among the non-benzodiazepines with similar effects, and the only z-drug schedule is for zopiclone, its parent compound. The principles of slow, patient-controlled reduction apply to Lunesta fully, and the schedule is built for the individual.

How Dr. Leeds’ practice approaches a Lunesta taper.

Dr. Leeds is an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida, and his practice is concierge, not insurance-based. He works with every patient directly, by telemedicine throughout Florida, and builds each Lunesta taper at the patient’s pace over months. He also helps patients taper other psychiatric medications. The full model is described on his medically supervised benzodiazepine tapering page, and anyone in Florida who is ready to come off Lunesta slowly and safely can Contact Dr. Leeds through the practice’s form.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.